CLINICAL_TRIALS
trial_result
· 2018-02-07
Clinical Trial Update: AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation [Phase 2]
Summary
Phase 2 trial update of AMD 3100 (Mozobil) for mobilizing stem cells in healthy donors; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Healthy | Phase 2 | Status: COMPLETED | Results posted: 2018-02-07